Sunday January 26, 2020

Bayer’s high hopes for new drug that prevents blood clots

Hopes are rising that Bayer’s blood-thinning pill, Rivaroxaban, could eventually become a standard treatment for preventing heart attacks, pulmonary embolisms and strokes.

Susan Mitchell

Deputy Editor and Health Editor

@susmitchellsbp
9th August, 2008

Hopes are rising that Bayer’s blood-thinning pill, Rivaroxaban, could eventually become a standard treatment for preventing heart attacks, pulmonary embolisms and strokes.

Tens of thousands of Irish people might some day take it following surgery or to prevent blood clots from forming. EU regulators recommended approval of Rivaroxaban last month. Final approval from the European Commission is expected within months.

Henrik Wulff, managing director of Bayer Ltd in Ireland, said Rivaroxaban would ‘‘revolutionise...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 3 weeks ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 4 years ago